Trial
NCT00575965
Simvastatin in Waldenstrom's Macroglobulinemia
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Dana-Farber Cancer Institute
Collaborators
—
Condition
Waldenstrom's Macroglobulinemia
Intervention
Simvastatin
Why stopped
Slow accrual led to early study termination.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-12-16